Shi Wei

Prof. Shi Wei

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2015 in American Journal of Clinical Pathology
Verified
Journal Article
Open access
PDF file
ASAbha Soni
Abha Soni
ZRZhiyong Ren
Zhiyong Ren
OHOmar Hameed
Omar Hameed
DCDiptiman Chanda
Diptiman Chanda
CMCharity J. Morgan
Charity J. Morgan
SWShi Wei
Shi Wei
Objectives:. The distant organs to which breast cancer preferentially metastasizes are of significant clinical importance.Methods:. We explored the re

1 November 2017 in Human Pathology
Verified
Journal Article
Closed access
KWKai Wang
Kai Wang
TSTiansheng Shen
Tiansheng Shen
GSGene P. Siegal
Gene P. Siegal
SWShi Wei
Shi Wei

1 July 2016 in Archives of Pathology & Laboratory Medicine
Verified
Journal Article
Closed access
SWShi Wei
Shi Wei
Context.— Papillary lesions of the breast, characterized by the presence of arborescent fibrovascular cores that support epithelial proliferation, constitute a heterogeneous group of neoplasms with overlapping clinical manifestation and histomorphologic features, but may have divergent biological behavior. These lesions are exclusively intraductal neoplasms, although an invasive carcinoma may rarely have a predominantly papillary architecture. Although recognition of a papillary architecture is typically not challenging, the histologic distinction of these entities is not always straightforward. Historically, different terminologies and variable criteria have been proposed for a given entity by various authorities. The difficulty in classifying these lesions has been further confounded by the scarcity of data and the heterogeneity across different studies with regard to the molecular genetic characteristics of this group of lesions. Objective.— To provide an overview focusing on the current concepts in the diagnosis and classification of papillary lesions of the breast incorporating recent molecular genetic advances. Data Sources.— Data were obtained from pertinent peer-reviewed English-language literature. Conclusions.— The recent evolution of molecular techniques has enhanced our knowledge of the pathogenesis of papillary carcinomas of the breast. This, along with emerging outcome studies, has led to prognosis-based reclassification of some of these entities. Additional studies focusing on the molecular signatures are needed to identify potential decision tools to further stratify these lesions with respect to prognostic significance.

3 July 2020 in Laboratory Investigation
Verified
Journal Article
Closed access
PDF file
RCRong Chen
Rong Chen
MQMorad Qarmali
Morad Qarmali
GSGene Siegal
Gene Siegal
SWShi Wei
Shi Wei

3 September 2023 in Pathology - Research and Practice
Verified
Journal Article
Closed access
SWShi Wei
Shi Wei

10 March 2021 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
FFFei Fei
Fei Fei
GSGene P. Siegal
Gene P. Siegal
SWShi Wei
Shi Wei